JP2021533193A5 - - Google Patents

Info

Publication number
JP2021533193A5
JP2021533193A5 JP2021529237A JP2021529237A JP2021533193A5 JP 2021533193 A5 JP2021533193 A5 JP 2021533193A5 JP 2021529237 A JP2021529237 A JP 2021529237A JP 2021529237 A JP2021529237 A JP 2021529237A JP 2021533193 A5 JP2021533193 A5 JP 2021533193A5
Authority
JP
Japan
Prior art keywords
approximately
composition
bis
use according
droplets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021529237A
Other languages
English (en)
Japanese (ja)
Other versions
JP7564101B2 (ja
JP2021533193A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/044489 external-priority patent/WO2020028558A1/en
Publication of JP2021533193A publication Critical patent/JP2021533193A/ja
Publication of JP2021533193A5 publication Critical patent/JP2021533193A5/ja
Application granted granted Critical
Publication of JP7564101B2 publication Critical patent/JP7564101B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021529237A 2018-07-31 2019-07-31 ビスマスチオール組成物及び使用方法 Active JP7564101B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862712563P 2018-07-31 2018-07-31
US62/712,563 2018-07-31
US201962800925P 2019-02-04 2019-02-04
US62/800,925 2019-02-04
PCT/US2019/044489 WO2020028558A1 (en) 2018-07-31 2019-07-31 Bismuth-thiol compositions and methods of use

Publications (3)

Publication Number Publication Date
JP2021533193A JP2021533193A (ja) 2021-12-02
JP2021533193A5 true JP2021533193A5 (https=) 2022-07-29
JP7564101B2 JP7564101B2 (ja) 2024-10-08

Family

ID=69231251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021529237A Active JP7564101B2 (ja) 2018-07-31 2019-07-31 ビスマスチオール組成物及び使用方法

Country Status (13)

Country Link
US (2) US11464749B2 (https=)
EP (1) EP3829307A4 (https=)
JP (1) JP7564101B2 (https=)
KR (1) KR20210084425A (https=)
CN (1) CN112804878A (https=)
AU (1) AU2019315509B2 (https=)
BR (1) BR112021001731A2 (https=)
CA (1) CA3107760A1 (https=)
IL (1) IL280414B2 (https=)
MX (2) MX2021001272A (https=)
SG (1) SG11202100823RA (https=)
WO (1) WO2020028558A1 (https=)
ZA (1) ZA202100780B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019312592B2 (en) 2018-07-31 2025-06-26 Microbion Corporation Bismuth-thiol compositions and methods for treating wounds
WO2020028558A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods of use
WO2021195236A1 (en) * 2020-03-24 2021-09-30 Microbion Corporation Bismuth thiol compounds and compositions and methods of treating microbial co-infections
WO2022159881A1 (en) * 2021-01-25 2022-07-28 Microbion Corporation Amorphous form of bismuth-1,2-ethanedithiol and methods of making
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
WO2023063827A1 (en) * 2021-10-15 2023-04-20 Omnicin Therapeutics B.V. Synergistic composition against pseudomonas aeruginosa
CA3248355A1 (en) * 2022-01-10 2023-07-13 Microbion Corporation METHODS OF TREATMENT FOR NON-TUBERCULOUS MYCOBACTERIAL DISEASES

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809971A (en) 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
USRE29409E (en) 1965-03-15 1977-09-20 Ventron Corporation Phenoxarsine compounds incorporated into resins with phenols
US3452034A (en) 1967-03-09 1969-06-24 American Cyanamid Co Substituted 2-(1,3,4-thiadiazol-2-yl)-4(5)-nitroimidazoles
ATE4908T1 (de) 1980-08-15 1983-10-15 Scott Bader Company Limited Anstrichzusammensetzungen.
US4596724A (en) 1984-05-15 1986-06-24 Marine Shield Corp. Anti-fouling coating composition, process for applying same and coating thereby obtained
US4788302A (en) 1985-06-14 1988-11-29 Duke University Anti-fouling compound and method of use
JPH0653735B2 (ja) 1987-08-03 1994-07-20 明治製菓株式会社 N−アルキルベンゼンスルホニルカルバモイル−5−クロロイソチアゾ−ル誘導体および殺微生物剤
ATE124864T1 (de) 1989-03-10 1995-07-15 Yamanouchi Pharma Co Ltd Die wirkstoffabgabe steuerndes überzugsmaterial für lang wirksame formulierungen.
US5229124A (en) 1990-04-02 1993-07-20 Morton International, Inc. Microbicides immobilized in water soluble thermoplastic resins and aqueous dispersions of microbicides prepared therefrom
US5194248A (en) 1990-06-21 1993-03-16 Trustees Of Boston University Compositions comprising vitamin D analog precursors and the use thereof
JPH04325569A (ja) 1991-04-24 1992-11-13 Ishihara Sangyo Kaisha Ltd 防汚塗料組成物
US6488912B1 (en) 1992-07-30 2002-12-03 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of dentoalveolar infections with taurolidine and/or taurultam
US5334389A (en) 1992-10-15 1994-08-02 Duke University Antifouling coating and method for using same
US5384176A (en) 1992-12-11 1995-01-24 Zimmerman; Richard C. Phenolic acid sulfate esters for prevention of marine biofouling
US6086921A (en) 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US5928671A (en) 1995-04-25 1999-07-27 Winthrop University Hospital Method and composition for inhibiting bacteria
US6558686B1 (en) 1995-11-08 2003-05-06 Baylor College Of Medicine Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor
US6071528A (en) 1997-02-19 2000-06-06 Ultradent Products, Inc. Adhesive antimicrobial and/or reparative dentin stimulating dental compositions and methods for forming and using such compositions
US6017936A (en) 1997-03-14 2000-01-25 Arch Chemicals, Inc. Method for producing particles of pyrithione salts and particles so produced
US5999828A (en) 1997-03-19 1999-12-07 Qualcomm Incorporated Multi-user wireless telephone having dual echo cancellers
US6455031B1 (en) 1997-06-18 2002-09-24 David G Davies Methods and compositions for controlling biofilm development
AU2003204105B2 (en) 1997-10-28 2005-11-17 Winthrop-University Hospital Metal/Thiol Biocides
JPH11158328A (ja) 1997-11-27 1999-06-15 Fujikura Rubber Ltd 抗菌性ゴム部品
AU2656799A (en) 1998-02-04 1999-08-23 Winthrop-University Hospital Metal-thiols as imminomodulating agents
GB9802355D0 (en) 1998-02-04 1998-04-01 Ciba Geigy Ag Organic compounds
US6465015B1 (en) 1998-02-24 2002-10-15 Arch Chemicals, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
TWI245763B (en) 1998-04-02 2005-12-21 Janssen Pharmaceutica Nv Biocidal benzylbiphenyl derivatives
AU6261499A (en) 1998-09-23 2000-04-10 Phycogen, Inc. Antifouling agents
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6261539B1 (en) 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6682724B2 (en) 1999-02-23 2004-01-27 Arch Chemcials, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
JP2000336080A (ja) 1999-05-28 2000-12-05 Nippon Bayer Agrochem Co Ltd イソチアゾールカルボキサミド類
WO2001064644A1 (en) 2000-03-01 2001-09-07 Nihon Bayer Agrochem K.K. Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
WO2002032387A1 (es) 2000-10-16 2002-04-25 Biocosmetics, S.L. Empleo del aceite de oliva en la elaboración de un producto para higiene oral para la eliminación o reducción de la placa bacteriana y/o bacterias presentes en la cavidad bucal
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6630172B2 (en) 2001-01-22 2003-10-07 Kareem I. Batarseh Microbicidal composition containing potassium sodium tartrate
US6582719B2 (en) 2001-02-02 2003-06-24 The Trustees Of Columbia University In The City Of New York Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms
PT1997478E (pt) 2001-02-15 2013-12-10 Access Pharma Inc Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
US6555599B2 (en) 2001-03-26 2003-04-29 Milliken & Company Antimicrobial vulcanized EPDM rubber articles
US6448306B1 (en) 2001-03-23 2002-09-10 Milliken & Company Antimicrobial articles made from nitrile or natural rubber
EP1381644A4 (en) 2001-03-23 2005-11-02 Milliken & Co ANTIMICROBIAL RUBBER COMPOSITIONS
US6730324B2 (en) 2001-04-20 2004-05-04 The University Of British Columbia Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
EP1531837A4 (en) 2001-06-07 2006-11-15 Chiou Consulting Inc COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF APHTEOUS ULCERS AND LESIONS DUE TO HERPES
US6638993B2 (en) 2001-12-12 2003-10-28 Milliken & Company Colored antimicrobial vulcanized rubber articles
US6579513B1 (en) 2002-01-03 2003-06-17 Playtex Products, Inc. Hygiene mouthspray composition
US7438925B2 (en) 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
JP4357166B2 (ja) 2002-10-21 2009-11-04 日揮触媒化成株式会社 抗菌・防黴・防藻性組成物
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US6861049B2 (en) 2002-11-12 2005-03-01 Douglas B. Harwood Aqueous slurries useful for cleaning the tongue and throat
US6848871B1 (en) 2002-12-19 2005-02-01 Cottrell, Inc. Strap tie-down system
JP2004307483A (ja) 2003-04-07 2004-11-04 Rohm & Haas Co 殺微生物組成物
US7060739B2 (en) 2003-04-25 2006-06-13 Milliken & Company Antimicrobial fluoroelastomer rubber articles and compositions
US6943205B2 (en) 2003-04-25 2005-09-13 Milliken & Company Antimicrobial articles and compositions made from styrene butadiene rubber
US6852782B2 (en) 2003-04-25 2005-02-08 Milliken & Company Antimicrobial articles and compositions made from non-silicone vulcanized rubber
US6875453B2 (en) 2003-07-18 2005-04-05 Manuel Viamonte, Jr. Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol
US7381751B2 (en) 2003-08-26 2008-06-03 Shantha Sarangapani Antimicrobial composition for medical articles
KR101297061B1 (ko) 2004-07-02 2013-08-19 베링거 인겔하임 인터내셔날 게엠베하 추진제로서 tg 227 ea 또는 tg 134 a를함유하는 에어로졸 현탁액 제형
ATE503465T1 (de) 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh Beladbare polyphosphazenhaltige teilchen für therapeutische und/oder diagnostische anwendungen sowie herstellungs- und verwendungsverfahren dafür
US7419681B2 (en) 2004-12-02 2008-09-02 Bioretec, Ltd. Method to enhance drug release from a drug-releasing material
US20090191254A1 (en) 2004-12-06 2009-07-30 The Govt. Of The U.S.A., Centers For Disease Control And Prevention Inhibition of biofilm formation using bacteriophage
US20060205838A1 (en) 2005-03-10 2006-09-14 Velamakanni Bhaskar V Hardenable antimicrobial dental compositions and methods
EP1888088A4 (en) 2005-05-26 2012-07-04 Chr Hansen As BACTERIAL REGULATION IN ANIMAL CONTAINMENT SYSTEMS
US7507281B2 (en) 2005-09-02 2009-03-24 Microban Products Company Antimicrobial cementitious composition, method and article
BRPI0617663A2 (pt) 2005-10-21 2011-08-02 Panacea Biotec Ltd composições aperfeiçoadas para terapia de cáncer
US8268395B2 (en) 2005-12-05 2012-09-18 E. I. Du Pont De Nemours And Company Method for providing resistance to biofouling in a porous support
JP4568232B2 (ja) 2006-01-06 2010-10-27 秀和 西松 人工骨頭保持具
JP2007332040A (ja) 2006-06-12 2007-12-27 Shinshu Univ カーボンナノチューブを含む抗菌剤とそれを用いた材料及び製剤
GB0618697D0 (en) 2006-09-22 2006-11-01 Syntopix Ltd Formulations
US20110008402A1 (en) 2006-10-13 2011-01-13 Kane Biotech Inc. Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof
EP2104558A2 (en) 2006-12-12 2009-09-30 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
EP2117611B1 (en) 2007-01-24 2014-07-30 Cook Medical Technologies LLC Biofilm-inhibiting medical products
US8343536B2 (en) 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products
US8282949B2 (en) 2007-05-18 2012-10-09 Sciessent Llc Bioactive acid agrichemical compositions and use thereof
WO2008150375A1 (en) 2007-06-01 2008-12-11 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
WO2009014549A1 (en) 2007-07-25 2009-01-29 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
EP2237788A4 (en) 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
US20090197003A1 (en) 2008-02-01 2009-08-06 Thomas Van Zandt Anti-fouling coatings, Compounds, and methods
WO2009102787A2 (en) 2008-02-12 2009-08-20 Boston Scientific Scimed, Inc. Medical implants with polysaccharide drug eluting coatings
US20110092589A1 (en) 2008-03-10 2011-04-21 The Charlotte-Mecklenburg Hospotal Authority Treatment of Inflammatory Conditions and Diseases with Metal-Thiols
EP2393491B1 (en) 2009-02-03 2020-04-22 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
US20200138033A1 (en) * 2009-02-03 2020-05-07 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
KR101966867B1 (ko) 2010-02-03 2019-04-08 마이크로비온 코포레이션 세균 균막의 치료 및 다른 용도를 포함하는, 생의학적 용도를 위한 방부제로서 비스무트-티올
JP2013518895A (ja) 2010-02-03 2013-05-23 マイクロビオン コーポレーション 細菌バイオフィルムの処置および他の使用をはじめとする、生体医学的使用のための消毒薬としてのビスマス−チオール
JP6336246B2 (ja) 2013-03-13 2018-06-06 大同化成工業株式会社 ナノ粒子化製剤及びその製造方法
US20140287039A1 (en) 2013-03-15 2014-09-25 Iceutica Inc. Abiraterone Acetate Formulation
EP3179982B1 (en) 2014-07-28 2023-07-19 Sun Pharma Advanced Research Company Ltd Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
JP6856620B2 (ja) 2015-07-27 2021-04-07 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドSun Pharma Advanced Research Company Limited 薬剤搭載ナノ樹脂粒子
WO2020028558A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods of use
AU2019312592B2 (en) 2018-07-31 2025-06-26 Microbion Corporation Bismuth-thiol compositions and methods for treating wounds

Similar Documents

Publication Publication Date Title
JP2021533193A5 (https=)
JP2023513106A5 (https=)
US10792289B2 (en) Use of aerosolized levofloxacin for treating cystic fibrosis
DK3221313T3 (en) COMBINATION THERAPY FOR TREATING INFECTIONS WITH RESISTANT BACTERIA
CA2504317A1 (en) Sustained release of antiinfectives
RU2008102651A (ru) Замедленное высвобождение противоинфекционных агентов
JP7564101B2 (ja) ビスマスチオール組成物及び使用方法
CN110520114A (zh) 包含银和抗生素的纳米体系及其用于治疗细菌感染的用途
Palmer Aerosolized antibiotics in the intensive care unit
Wood et al. Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia
CN101837126A (zh) 头孢类抗菌药物组合物及其药物制剂
Karki et al. Is it worth adding systemic antibiotics to inhalational tobramycin therapy to treat pseudomonas infections in cystic fibrosis?
Jang et al. The comparative efficacy of colistin monotherapy and combination therapy based on in vitro antimicrobial synergy in ventilator-associated pneumonia caused by multi-drug resistant Acinetobacter baumannii.
Perez Does second place count? Lessons from a major discrepancy between carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Enterobacter cloacae in a one-year follow-up study
La-ongsuwan et al. CORRELATION BETWEEN THE ANTIMICROBIALS UTILIZATION AND ANTIMICROBIAL-RESISTANCE IN PRASAT NEUROLOGICAL INSTITUTE
Dharmapalan OVERVIEW OF ANTIBIOTICS
Unni Newer Antibiotics: Need for More Studies in Neonates and Children
Takemura et al. 1252. In Vitro Activity of Cefiderocol Against Metallo-β-Lactamase-Producing Gram-Negative Bacteria Collected in North America and Europe Between 2014 and 2017: SIDERO-WT-2014–2016 Studies
Shteinberg et al. Long-Term Inhaled Antibiotic Treatment in Bronchiectasis
Wang et al. Ursolic acid and resveratrol inhibit the biofilm formation and transcriptome analysis in MSSA or not?
WO2020167429A1 (en) An antibiotic formulation for use in treating bronchiectasis
AU2015275224C1 (en) Use of aerosolized levofloxacin for treating cystic fibrosis
Schriever et al. Antimicrobial Agents
Tümmler aeruginosa [version 1; peer review: 2 approved]
Johnson et al. Inhaled antibiotics for bronchiectasis: are we there yet?